Shilpa Medicare
Shilpa Medicare Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe and the United States. Founded in 1987, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals, particularly in oncology and other therapeutic areas. Shilpa Medicare is renowned for its innovative approach to drug formulation and delivery, offering a diverse portfolio of products that includes active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with global healthcare providers. With a focus on research and development, Shilpa Medicare continues to advance its mission of improving patient outcomes worldwide.
DitchCarbon Score
How does Shilpa Medicare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shilpa Medicare's score of 18 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shilpa Medicare's reported carbon emissions
In 2023, Shilpa Medicare reported total carbon emissions of approximately 15,000,000 kg CO2e, comprising 1,523,280 kg CO2e from Scope 1, 14,691,660 kg CO2e from Scope 2, and 710,410 kg CO2e from Scope 3 emissions. This represents a significant reduction from 2022, where total emissions were about 22,000,000 kg CO2e, with Scope 1 at 3,900,120 kg CO2e and Scope 2 at 22,246,110 kg CO2e. The company has committed to achieving net-zero emissions by 2050, with targets set across all scopes of emissions. Shilpa Medicare's long-term climate strategy includes a commitment to reduce its carbon footprint, aligning with the Science Based Targets initiative (SBTi). The company is actively working towards these goals, demonstrating a proactive approach to climate change and sustainability within the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 3,900,120 | 0,000,000 | 0,000,000 |
| Scope 2 | 22,246,110 | 00,000,000 | 00,000,000 |
| Scope 3 | 877,770 | 000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shilpa Medicare is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
